Provexis Share Discussion Threads

[redprince] 08/3/2018 19:43

Actually you did lafin.You promised last year that you were done here but unfortunately that promise proved too good to be true.

Apparently you suffer from a selective memory.

Your posts get in the way of a genuinely interesting and relevent debate.

I genuinely wish you would honour your promise and leave this bb.

Just being honest.

[lafin] 08/3/2018 19:34

I have NEVER promised not to post on here.
Even if I had I could change my mind.
You said that on blue board too.I call THAT provocative.

Put me on filter if my posts anger you so much.

[gunsofmarscapone] 08/3/2018 19:08

Its not ‘pernickety217; but valid syllogistic reasoning. I would welcome an intelligent poster to be honest, regardless of how rigorous they are in language and other areas.

[redprince] 08/3/2018 18:03

The above quote posted here for the purpose of provocation only by a poster who promised they would not post here any longer.

The above post if read properly actually illustrates the hurdles pxs face in making anything out of FF now.

It crucially fails to address the lack of funds that prevent pxs from doing anything other than more open ended research now in China.
Its been 8 years amd noone seems bothered by fact that we are all being kept in the dark regarding reasons for non take up by the large co's that they have been talking to for many years now.

[lafin] 08/3/2018 12:52

part of a post by someone on a red board
"death from Cardiovascular disease is a large proportion of the total in China, whatever the number per year may be. The key point is that the percentage is on the increase. Of course, many won't care until it is too late. Our target market is those who take an active interest in staying healthy,across the globe, and the task is education. Budget restrictions prevent Provexis from going mainstream, DSM and brand partners continue to chip away. So much of advertising is not that obvious these days, targeting consumers online in specific areas is highly sophisticated.

Well funded just over half a year ago. More patents, more health claims, targetting a greater percentage of the population than ever before. IMO we just need revenue increases to go that one next step towards covering overheads to entirely change mood and outlook. The lights are very much on."

[lafin] 08/3/2018 12:28

pernickety

[librag] 08/3/2018 12:03

Try not to simply regurgitate quotes as facts.

Direct quote from your post, " ... a massive market opportunity to meet demand for the growing year on year of the 40% of the billion plus people in China dieing from C.V. problems."

I'll give you a clue. They're not all dieing (sic), present tense.
For the hard-of-thinking, the article should have clarified that they're referring to 40% of the chinese who die now (10M give or take) NOT 40% of a billion (400M give or take). Many like you will see the latter and from that convince themselves that we're on a no-brainer. We're most certainly not.

[wheelds] 07/3/2018 18:38

Direct from the article:-

"More than 40 percent of Chinese die of CV disease - the first cause of death in China."

Thats what the report says.

[lafin] 07/3/2018 12:37

deleted my posts

[librag] 07/3/2018 12:01

winner; reread his post.
RP; sad but true.

[lafin] 07/3/2018 11:55

I suggest you read the half year report again carefully.

[redprince] 07/3/2018 07:15

We are severely restricted in that we have no funds to do anything.Further dilution at these levels is imho unthinkable.A far too high % of what little money we have is imo being wasted on the underperforming bod salaries.I am amazed that so many substantial shareholders have tolerated this fact alone.I lost all faith and respect for them some time ago.

[winner31] 06/3/2018 20:54

You miss the point! for the 9.8 million its too late ,its the rest that are at risk

[wheelds] 06/3/2018 10:46

By-Health, the Chinese company, in colaboration with Provexis and DSM, have a massive market opportunity to meet demand for the growing year on year of the 40% of the billion plus people in China dieing from C.V. problems.
Hence, more clarity as to why Provexis applied for a patent to cover Fruitflow as a natural way to manage the ill effects caused by bad air pollution, as in China.

The report is serious:-

"The report is not only the most authoritative large-scale integrated CV health index, but also the world£s first national level index evaluation on CV disease prevention and control".

"Eight institutions, such as the Chinese Center for Disease Control and Prevention, and more than 40 experts participated in creating the health index."

[librag] 06/3/2018 09:38

I'm unsure. Like many on the boards I believe in the product but running the business side is beyond me. Intellectual property, more R&D and JV with pharma seem logical but does the BoD have the vision? They certainly don't have a good track record.

GL.

[gunsofmarscapone] 05/3/2018 23:10

Well most of us have been in paper loss situations, how can a recovery strategy be executed? What is a logical time horizon?

[librag] 05/3/2018 17:55

It's not rare at all but thanks for the acknowledgement.

Let's not go down the can't prove a negative road unless you're a crystal gazer?

FYI, I've lost too much.

[gunsofmarscapone] 05/3/2018 16:15

How much money have you lost on this LibraG.

[gunsofmarscapone] 05/3/2018 16:06

Actually, and quite rarely, you are correct; however it is a non sequitur that the abscence of large scale placebo double blind trials will not lead to commercial success. The non existence of such trials is not indicative of FF being not effective.

Or indeed the other way round.

[librag] 05/3/2018 12:59

NoR; re. the blue channel.

The only effective way to 'advertise' to Doctors is via the medical press and meetings. Even then, suffice to say it will only work with clinically relevant research. The illiterati think that we have our case proven (clinically) ... we don't I'm afraid.

[gunsofmarscapone] 02/3/2018 16:36

Has to be amongst the world’s top twenty nerdiest posters. I honestly think that the stuff, rendered as it is from a small component of actual tomatoes can be made more cheaply but that is where the real innovation lies, in terms of the small band of excitable investors making a return on their positions.

I’ll count up my shares and make a decision of how many to hold.